載入...
As a potential treatment of COVID-19: Montelukast
It has been hypothesized that Montelukast, a cysteinyl leukotriene (cysLT) receptor antagonist, with effects of anti-inflammatory, suppress oxidative stress and reduce affect cytokine production, may limited progression of the disease on COVID-19 infection.
Na minha lista:
| 發表在: | Med Hypotheses |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier Ltd.
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7211747/ https://ncbi.nlm.nih.gov/pubmed/32416408 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mehy.2020.109828 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|